| Areas | |
|---|---|
| Serie de libros (96) |
1378
|
| Nachhaltigkeit |
3
|
| Gesundheitswesen |
1
|
| Letra |
2363
|
| Ciencias Naturales |
5406
|
| Matemática | 229 |
| Informática | 319 |
| Física | 980 |
| Química | 1363 |
| Geociencias | 131 |
| Medicina humana | 243 |
| Estomatología | 10 |
| Veterinaria | 108 |
| Farmacia | 147 |
| Biología | 835 |
| Bioquímica, biología molecular, tecnología genética | 121 |
| Biofísica | 25 |
| Nutrición | 45 |
| Agricultura | 1004 |
| Silvicultura | 201 |
| Horticultura | 20 |
| Ecología y conservación de la tierra | 148 |
| Ciencias Ingeniería |
1791
|
| General |
97
|
|
Leitlinien Unfallchirurgie
5. Auflage bestellen |
|
Lectura de prueba, PDF (3,9 MB)
Indice, PDF (73 KB)
Eukaryotic cells are divided into a nuclear and a cytoplasmic compartment. This separates transcription from translation and makes gene expression dependent on nucleocytoplasmic transport. The members of the importin β superfamily function as shuttling nuclear transport receptors (NTRs) that recognize and actively transport cargoes through nuclear pores. An estimated 5 000 to 10 000 different human proteins are subject to active nuclear transport. Numerous cargo/NTR pairs have been identified, however, we are still far from a complete understanding as it has been very challenging to setup a systematic in vivo analysis that integrates the impact of all transport pathways.
In this study, we obtained anti-NTR nanobodies against TRN1, Xpo4, Xpo7, and CAS. Our aim was to identify nanobodies, and prepare nanobody fusions, that impede nuclear pore-passage of the targeted NTR and thus, interrupt a given transport cycle. These nanobody fusions were observed to inhibit the partition of NTR/cargo complexes into a reconstituted FG phase. We also observed that the nanobodies and nanobody fusions inhibit NTR transport in permeabilized cells.
| ISBN-13 (Impresion) | 9783736978478 |
| ISBN-13 (E-Book) | 9783736968479 |
| Formato | A5 |
| Idioma | Inglés |
| Numero de paginas | 136 |
| Laminacion de la cubierta | Brillante |
| Edicion | 1. |
| Lugar de publicacion | Göttingen |
| Lugar de la disertacion | Universität Göttingen |
| Fecha de publicacion | 07.08.2023 |
| Clasificacion simple | Tesis doctoral |
| Area |
Bioquímica, biología molecular, tecnología genética
|
| Palabras claves | eukaryotic cells, nucleus, compartmentalization, nucleocytoplasmic transport, importin, shuttling, nuclear transport receptors (NTRs), nuclear pore complex (NPC), importins, exportins, biportins, export complex, transport pathways, anti-NTR nanobodies, Transportin 1 (TRN1), Exportin 4 (Xpo4), Exportin 7 (Xpo7), CAS, nanobody fusions, impede nuclear pore passage, transport cycle, inhibitor, inhibition, NTR/cargo complexes, FG phase, NTR-meidated transport, permeabilized cells, Ran binding, transport block, nanobodies (Nbs), nucleoporins (Nups), tag-Nbs, NTR blockers, eukaryotische Zellen, Zellkern, Kompartimentierung, nukleozytoplasmatischer Transport, Kerntransportrezeptoren (NTRs), Kernporenkomplex (NPC), Nanokörperfusionen, NTR-vermeideter Transport, permeabilisierte Zellen, NTR-Blocker |
| URL para pagina web externa | https://www.mpinat.mpg.de |